Trials / Unknown
UnknownNCT01249066
Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- China Medical University Hospital · Academic / Other
- Sex
- All
- Age
- 25 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
AMP-activated protein kinase (AMPK) is an evolutionally conserved protein kinase that serves as an energy guardian to help cells adapt to various metabolic stress including hypoxia. Because the role of AMPK in cancers has not been fully elucidated, in this study we investigated the expression and activation of AMPK in lung adenocarcinoma (LADC) cells and tissue.
Conditions
Timeline
- Start date
- 2010-09-01
- First posted
- 2010-11-29
- Last updated
- 2010-11-29
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01249066. Inclusion in this directory is not an endorsement.